Showing results (491-500 of 549) with videos related to

Sort By:
Pageof 55
The American Journal of Tropical Medicine and Hygiene|July 19, 2021
Nosocomial Respiratory Infections in a Rural Zambian HospitalGideon Loevinsohn, Justin Hardick, Thomas Mehoke, et al.
Clinical Infectious Diseases : an Official Publication of the Infectious Diseases Society of America|May 20, 2021
Differential Cytokine Signatures of Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) and Influenza Infection Highlight Key Differences in PathobiologyAndrew H Karaba, Weiqiang Zhou, Leon L Hsieh, et al.
Elife|November 8, 2017
Otoferlin acts as a Ca2+ sensor for vesicle fusion and vesicle pool replenishment at auditory hair cell ribbon synapsesNicolas Michalski, Juan D Goutman, Sarah Marie Auclair, et al.
Plos One|February 21, 2025
COVID-19 symptom severity and duration among outpatients, July 2021-May 2023: The PROTECT observational studyBhavya Vashi, Kristen Pettrone, Claire S Wilson, et al.
Annals of Neurology|March 3, 2017
Homozygous mutations in VAMP1 cause a presynaptic congenital myasthenic syndromeVincenzo Salpietro, Weichun Lin, Andrea Delle Vedove, et al.
Plos One|July 8, 2016
The IRIDICA BAC BSI Assay: Rapid, Sensitive and Culture-Independent Identification of Bacteria and Candida in BloodDavid Metzgar, Mark W Frinder, Richard E Rothman, et al.
Trials|January 28, 2023
The Determining Effective Testing in Emergency Departments and Care Coordination on Treatment Outcomes (DETECT) for Hepatitis C (Hep C) Linkage-to-Care Trial: rationale and design of an emergency department-based randomized clinical trial of linkage-to-care strategies for hepatitis CSarah E Rowan, Jason Haukoos, Kevin F Kamis, et al.
BMC Infectious Diseases|September 1, 2023
Evaluating the impact of point-of-care HIV viral load assessment on linkage to care in Baltimore, MD: a randomized controlled trialMohammad Harris Bayan, Travis Smalls, Alec Boudreau, et al.
JAMA|July 9, 2025
Hepatitis C Screening in Emergency Departments: The DETECT Hep C Randomized Clinical TrialJason Haukoos, Richard E Rothman, James W Galbraith, et al.
Proceedings of the National Academy of Sciences of the United States of America|November 2, 2022
Anti-PF4 antibodies associated with disease severity in COVID-19Qingbo Liu, Huiyi Miao, Shuai Li, et al.
Pageof 55